CheckMyRecalls

SOMERSET THERAPEUTICS LLC recalls Dexamethasone Sodium Phosphate…

SOMERSET THERAPEUTICS LLC recalls Dexamethasone Sodium Phosphate Injection

Published
25 Mar 2026
Units affected
62190 vials
Agency
FDA
Country
United States

The hazard

Failed Impurities/Degradation Specifications - OOS impurities result observed during long term stability testing at product expiry (24 months) were above specs for these impurities: Dexamethasone Sodium Phosphate EP impurity G (Impurity RU 49336) and dexamethasone formate.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Dexamethasone Sodium Phosphate Injection, USP, 100 mg/ 10 mL, (10 mg/mL), 10x10 mL Multiple Dose Vials, Rx only, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873, NDC carton: 70069-025-10; NDC vial: 70069-025-01

Brand / company
SOMERSET THERAPEUTICS LLC
Codes / lots
Lot #: A240421, Exp 07/31/2026
Distribution
Nationwide in the USA
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 25 Mar 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.